Publications dans lesquelles il/elle collabore avec OLIVIA HURTADO MORENO (47)

2023

  1. Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice

    Frontiers in Cellular Neuroscience, Vol. 17

  2. Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice

    Stroke, Vol. 54, Núm. 10, pp. 2652-2665

2019

  1. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke

    Brain, Behavior, and Immunity, Vol. 80, pp. 573-582

2017

  1. Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke

    Stroke, Vol. 48, Núm. 1, pp. 204-212

  2. Specific Features of SVZ Neurogenesis after Cortical Ischemia: A Longitudinal Study

    Scientific Reports, Vol. 7, Núm. 1

2014

  1. Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways

    Neuroscience, Vol. 268, pp. 48-65

  2. Polarization of Macrophages/Microglia toward an M2 Phenotype as a Therapeutic Strategy for Stroke Treatment

    Rational Basis for Clinical Translation in Stroke Therapy (CRC Press), pp. 381-392

2013

  1. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke

    Journal of Neurochemistry, Vol. 126, Núm. 6, pp. 819-826

  2. Silent information regulator 1 protects the brain against cerebral ischemic damage

    Stroke, Vol. 44, Núm. 8, pp. 2333-2337

2012

  1. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation

    Neurochemistry International, Vol. 61, Núm. 1, pp. 119-127

  2. Velázquez. Manual de farmacología básica y clínica

    Editorial Médica Panamericana

2011

  1. Neuroprotection and recovery: Recent data at the bench on citicoline

    Stroke

  2. Tests neurológicos para la evaluación del pronóstico funcional en modelos de ictus isquémico en roedores

    Revista de Neurologia, Vol. 53, Núm. 10, pp. 607-618

2010

  1. Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model

    Neuroscience, Vol. 171, Núm. 3, pp. 885-892

2009

  1. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 296, Núm. 4

  2. Synthesis of lipoxin A 4 by 5-lipoxygenase mediates pparγ-dependent, neuroprotective effects of rosiglitazone in experimental stroke

    Journal of Neuroscience, Vol. 29, Núm. 12, pp. 3875-3884

  3. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning

    Journal of Neurochemistry, Vol. 109, Núm. 1, pp. 287-294

  4. Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia

    BMC Molecular Biology, Vol. 10

2008

  1. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke

    Circulation, Vol. 118, Núm. 14, pp. 1450-1459

  2. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke

    Neurobiology of Disease, Vol. 29, Núm. 1, pp. 123-131